Suchergebnisse - "Brentuximab Vedotin"

PubPharm (1.407)

1

Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma : the real-world US CONNECT study

enthalten in: Future oncology (London, England) | 2024

von Evens, A. | Yu, K. | Liu, N. | +6

2

Severe insulin resistance in a patient with diabetes after treatment with brentuximab vedotin

enthalten in: BMJ case reports | 2024

von Peeters, G. | Verhaegen, A.

3

Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy

enthalten in: European journal of neurology | 2024

von Matthys, A. | Bardel, B. | Le Bras, F. | +9

4

Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy

enthalten in: Virchows Archiv : an international journal of pathology | 2024

von Kaimi, Y. | Takahashi, Y. | Taniguchi, H. | +9

5

Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma

enthalten in: Future oncology (London, England) | 2024

von Dharmani, C. | Unni, S. | Pham, N. | +10

6

Polatuzumab vedotin pharmacokinetics in a hemodialysis patient with diffuse large B-cell lymphoma

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Yasuda, H. | Kaga, N. | Taka, H. | +7

7

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1

enthalten in: Haematologica | 2024

von Crosswell, H. | LaCasce, A. | Bartlett, N. | +9

8

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy

enthalten in: Blood | 2024

von Friedberg, J. | Bordoni, R. | Patel-Donnelly, D. | +8

CommentIn: Blood. 2024 Feb 29;143(9):741-742. - PMID 38421817

9

Toward a cure for cHL without chemotherapy

enthalten in: Blood | 2024

von Lynch, R.

CommentOn: Blood. 2024 Feb 29;143(9):786-795. - PMID 37946283

10

Safety and effectiveness of the combination of systemic gemcitabine and intralesional brentuximab vedotin in tumor-stage mycosis fungoides

enthalten in: International journal of dermatology | 2024

von Torre-Castro, J. | Recio-Monescillo, M. | Castillo Bazan, E. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[141]